These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

347 related items for PubMed ID: 34172466

  • 1. Blood eosinophil counts in the general population and airways disease: a comprehensive review and meta-analysis.
    Benson VS, Hartl S, Barnes N, Galwey N, Van Dyke MK, Kwon N.
    Eur Respir J; 2022 Jan; 59(1):. PubMed ID: 34172466
    [Abstract] [Full Text] [Related]

  • 2. Demographic and Clinical Characteristics of COPD Patients at Different Blood Eosinophil Levels in the UK Clinical Practice Research Datalink.
    Landis S, Suruki R, Maskell J, Bonar K, Hilton E, Compton C.
    COPD; 2018 Apr; 15(2):177-184. PubMed ID: 29558236
    [Abstract] [Full Text] [Related]

  • 3. Clinical And Economic Burden Of Eosinophilic COPD In A Large Retrospective US Cohort.
    Trudo F, Kallenbach L, Vasey J, Chung Y, Wilk A, Slipski L, O'Brien D, Strange C.
    Int J Chron Obstruct Pulmon Dis; 2019 Apr; 14():2625-2637. PubMed ID: 32063703
    [Abstract] [Full Text] [Related]

  • 4. Exacerbations and health care resource use among patients with COPD in relation to blood eosinophil counts.
    Müllerová H, Hahn B, Simard EP, Mu G, Hatipoğlu U.
    Int J Chron Obstruct Pulmon Dis; 2019 Apr; 14():683-692. PubMed ID: 30962682
    [Abstract] [Full Text] [Related]

  • 5. Relationship between blood eosinophils and clinical characteristics in a cross-sectional study of a US population-based COPD cohort.
    DiSantostefano RL, Hinds D, Le HV, Barnes NC.
    Respir Med; 2016 Mar; 112():88-96. PubMed ID: 26872700
    [Abstract] [Full Text] [Related]

  • 6. Blood eosinophil count in the general population: typical values and potential confounders.
    Hartl S, Breyer MK, Burghuber OC, Ofenheimer A, Schrott A, Urban MH, Agusti A, Studnicka M, Wouters EFM, Breyer-Kohansal R.
    Eur Respir J; 2020 May; 55(5):. PubMed ID: 32060069
    [Abstract] [Full Text] [Related]

  • 7. Blood eosinophil count variability in chronic obstructive pulmonary disease and severe asthma.
    Abe Y, Suzuki M, Kimura H, Shimizu K, Takei N, Oguma A, Matsumoto-Sasaki M, Goudarzi H, Makita H, Nishimura M, Konno S.
    Allergol Int; 2023 Jul; 72(3):402-410. PubMed ID: 36586746
    [Abstract] [Full Text] [Related]

  • 8. Both exhaled nitric oxide and blood eosinophil count were associated with mild allergic asthma only in non-smokers.
    Giovannelli J, Chérot-Kornobis N, Hulo S, Ciuchete A, Clément G, Amouyel P, Matran R, Dauchet L.
    Clin Exp Allergy; 2016 Apr; 46(4):543-54. PubMed ID: 26542195
    [Abstract] [Full Text] [Related]

  • 9. Clinical features and three-year prognosis of AECOPD patients with different levels of blood eosinophils.
    Ruiying W, Zhaoyun, Jianying X.
    Heart Lung; 2022 Apr; 56():29-39. PubMed ID: 35687923
    [Abstract] [Full Text] [Related]

  • 10. A retrospective cohort study in severe asthma describing commonly measured biomarkers: Eosinophil count and IgE levels.
    Haughney J, Morice A, Blyth KG, Lee AJ, Coutts A, McKnight E, Pavord I.
    Respir Med; 2018 Jan; 134():117-123. PubMed ID: 29413497
    [Abstract] [Full Text] [Related]

  • 11. Clinical utility of fractional exhaled nitric oxide and blood eosinophils counts in the diagnosis of asthma-COPD overlap.
    Takayama Y, Ohnishi H, Ogasawara F, Oyama K, Kubota T, Yokoyama A.
    Int J Chron Obstruct Pulmon Dis; 2018 Jan; 13():2525-2532. PubMed ID: 30174422
    [Abstract] [Full Text] [Related]

  • 12. Association of sputum and blood eosinophil concentrations with clinical measures of COPD severity: an analysis of the SPIROMICS cohort.
    Hastie AT, Martinez FJ, Curtis JL, Doerschuk CM, Hansel NN, Christenson S, Putcha N, Ortega VE, Li X, Barr RG, Carretta EE, Couper DJ, Cooper CB, Hoffman EA, Kanner RE, Kleerup E, O'Neal WK, Paine R, Peters SP, Alexis NE, Woodruff PG, Han MK, Meyers DA, Bleecker ER, SPIROMICS investigators.
    Lancet Respir Med; 2017 Dec; 5(12):956-967. PubMed ID: 29146301
    [Abstract] [Full Text] [Related]

  • 13. Evaluation of the Characteristics of Asthma in Severe and Extremely Severe COPD.
    Chen FJ, Lin GP, Huang XY, Liu YL, Zeng ZM, Guo YB.
    Int J Chron Obstruct Pulmon Dis; 2019 Dec; 14():2663-2671. PubMed ID: 31819399
    [Abstract] [Full Text] [Related]

  • 14. Serum eosinophil cationic protein in relation to bronchial asthma in a young Swedish population.
    Björnsson E, Janson C, Håkansson L, Enander I, Venge P, Boman G.
    Allergy; 1994 Oct; 49(9):730-6. PubMed ID: 7695062
    [Abstract] [Full Text] [Related]

  • 15. Heterogeneity of asthma according to blood inflammatory patterns.
    Nadif R, Siroux V, Oryszczyn MP, Ravault C, Pison C, Pin I, Kauffmann F, Epidemiological study on the Genetics and Environment of Asthma (EGEA).
    Thorax; 2009 May; 64(5):374-80. PubMed ID: 19131450
    [Abstract] [Full Text] [Related]

  • 16. Inhaled corticosteroids, blood eosinophils, and FEV1 decline in patients with COPD in a large UK primary health care setting.
    Whittaker HR, Müllerova H, Jarvis D, Barnes NC, Jones PW, Compton CH, Kiddle SJ, Quint JK.
    Int J Chron Obstruct Pulmon Dis; 2019 May; 14():1063-1073. PubMed ID: 31213788
    [Abstract] [Full Text] [Related]

  • 17. Benefits of budesonide/glycopyrronium/formoterol fumarate dihydrate on lung function and exacerbations of COPD: a post-hoc analysis of the KRONOS study by blood eosinophil level and exacerbation history.
    Muro S, Kawayama T, Sugiura H, Seki M, Duncan EA, Bowen K, Marshall J, Megally A, Patel M.
    Respir Res; 2024 Aug 05; 25(1):297. PubMed ID: 39103901
    [Abstract] [Full Text] [Related]

  • 18. Blood Eosinophils as Biomarkers to Drive Treatment Choices in Asthma and COPD.
    Kostikas K, Brindicci C, Patalano F.
    Curr Drug Targets; 2018 Aug 05; 19(16):1882-1896. PubMed ID: 29437007
    [Abstract] [Full Text] [Related]

  • 19. Variability in Blood Eosinophil Counts in Patients with Eosinophilic Asthma.
    Corren J, Du E, Gubbi A, Vanlandingham R.
    J Allergy Clin Immunol Pract; 2021 Mar 05; 9(3):1224-1231.e9. PubMed ID: 33130147
    [Abstract] [Full Text] [Related]

  • 20. The Value of Inflammatory Biomarkers in Differentiating Asthma-COPD Overlap from COPD.
    Li M, Yang T, He R, Li A, Dang W, Liu X, Chen M.
    Int J Chron Obstruct Pulmon Dis; 2020 Mar 05; 15():3025-3037. PubMed ID: 33244228
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.